XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment and Geographical Information (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of Business Segment Information Business Segment Information
Three months endedNine months ended
September 30,October 1,September 30,October 1,
(In millions)2023202220232022
Revenues
Life Sciences Solutions
$2,433 $2,962 $7,508 $10,485 
Analytical Instruments
1,754 1,621 5,226 4,746 
Specialty Diagnostics
1,083 1,065 3,300 3,648 
Laboratory Products and Biopharma Services
5,728 5,585 17,322 16,564 
Eliminations
(424)(556)(1,385)(1,978)
Consolidated revenues
10,574 10,677 31,971 33,465 
Segment Income
Life Sciences Solutions
872 1,039 2,525 4,542 
Analytical Instruments
468 386 1,321 1,031 
Specialty Diagnostics
283 220 860 816 
Laboratory Products and Biopharma Services
937 725 2,554 2,036 
Subtotal reportable segments
2,560 2,370 7,260 8,425 
Cost of revenues adjustments
(14)(22)(73)(41)
Selling, general and administrative expenses adjustments
(14)(11)(28)10 
Restructuring and other costs
(84)(33)(379)(59)
Amortization of acquisition-related intangible assets
(584)(594)(1,775)(1,803)
Consolidated operating income
1,864 1,710 5,005 6,532 
Interest income 246 68 570 122 
Interest expense(359)(173)(985)(457)
Other income/(expense)
14 (4)(32)(139)
Consolidated income before taxes
$1,765 $1,601 $4,558 $6,058 
Schedule of Revenue by Country Based on Customer Location
Three months endedNine months ended
(In millions)September 30, 2023October 1, 2022September 30, 2023October 1, 2022
Revenues
United States
$5,490 $5,787 $16,608 $17,730 
Other
5,084 4,890 15,363 15,735 
Consolidated revenues
$10,574 $10,677 $31,971 $33,465